The U.S. Food and Drug Administration (FDA) is restricting the use of the Johnson & Johnson vaccine due to the risk of blood clots. The FDA is also investigating reports of viral relapses following the use of Pfizer’s COVID-19 pill.
FDA Limits J&J Vaccine Over Blood Clot Risk
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.